Efficient production of inhibitor-free foamy virus glycoprotein-containing retroviral vectors by proteoglycan-deficient packaging cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Molecular therapy. 26,S. 394-412
- Ereignis
-
Veröffentlichung
- (wo)
-
Dresden
- (wer)
-
Technische Universität Dresden
- (wann)
-
2024
- Urheber
-
Munz, Clara Marie
Kreher, Henriette
Erdbeer, Alexander
Stanke, Nicole
Richter, Stefanie
Westphal, Dana
Yi, Buqing
Behrendt, Rayk
Lindel, Fabian
Lindemann, Dirk
- URN
-
urn:nbn:de:bsz:14-qucosa2-916791
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:49 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Munz, Clara Marie
- Kreher, Henriette
- Erdbeer, Alexander
- Stanke, Nicole
- Richter, Stefanie
- Westphal, Dana
- Yi, Buqing
- Behrendt, Rayk
- Lindel, Fabian
- Lindemann, Dirk
- Technische Universität Dresden
Entstanden
- 2024
Ähnliche Objekte (12)
Production of retroviral vectors in continuous high cell density culture
Efficient gene silencing in tumor tissue using replication-competent retroviral vectors
Optimization of retroviral packaging cells for scale-up of vector production
Gene therapy of malignant glioma with retroviral vectors and tumorinfiltrating progenitor cells
Fusoselect : cell-cell fusion activity engineered by directed evolution of a retroviral glycoprotein
Measles virus glycoprotein-based lentiviral targeting vectors that avoid neutralizing antibodies
Gene therapy of malignant glioma with retroviral vectors and tumor-infiltrating progenitor cells
Establishment of a clinically applicable stable packaging cell line for alpharetroviral SIN vectors
Retroviral reverse transcriptases
Development of a gene therapy approach for the treatment of human mammary carcinoma using tissue specific retroviral vectors
Development of a gene therapy approach for the treatment of human mammary carcinoma using tissue specific retroviral vectors
Epigenetic regulation of lentiviral and retroviral vectors in murine embryonic stem (ES) cells and genetic modification of ES cells with lentiviral vectors for application in regenerative medicine
Production of retroviral vectors in continuous high cell density culture
Efficient gene silencing in tumor tissue using replication-competent retroviral vectors
Optimization of retroviral packaging cells for scale-up of vector production
Gene therapy of malignant glioma with retroviral vectors and tumorinfiltrating progenitor cells
Fusoselect : cell-cell fusion activity engineered by directed evolution of a retroviral glycoprotein
Measles virus glycoprotein-based lentiviral targeting vectors that avoid neutralizing antibodies
Gene therapy of malignant glioma with retroviral vectors and tumor-infiltrating progenitor cells
Establishment of a clinically applicable stable packaging cell line for alpharetroviral SIN vectors
Retroviral reverse transcriptases
Development of a gene therapy approach for the treatment of human mammary carcinoma using tissue specific retroviral vectors
Development of a gene therapy approach for the treatment of human mammary carcinoma using tissue specific retroviral vectors
Epigenetic regulation of lentiviral and retroviral vectors in murine embryonic stem (ES) cells and genetic modification of ES cells with lentiviral vectors for application in regenerative medicine
Production of retroviral vectors in continuous high cell density culture
Efficient gene silencing in tumor tissue using replication-competent retroviral vectors
Optimization of retroviral packaging cells for scale-up of vector production
Gene therapy of malignant glioma with retroviral vectors and tumorinfiltrating progenitor cells
Fusoselect : cell-cell fusion activity engineered by directed evolution of a retroviral glycoprotein
Measles virus glycoprotein-based lentiviral targeting vectors that avoid neutralizing antibodies
Gene therapy of malignant glioma with retroviral vectors and tumor-infiltrating progenitor cells
Establishment of a clinically applicable stable packaging cell line for alpharetroviral SIN vectors
Retroviral reverse transcriptases
Development of a gene therapy approach for the treatment of human mammary carcinoma using tissue specific retroviral vectors
Development of a gene therapy approach for the treatment of human mammary carcinoma using tissue specific retroviral vectors